Lilian Yansheng Zhou
Known title: DirectorCIK: 0002003105
Lilian Yansheng Zhou's purchase track record
Lilian Yansheng Zhou has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/6/2023 | STAA | $26K | +16.0% | +32.7% | +17.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| STAA | ▲ Buy | Grant | 3,530 | $100K | 6/12/2026 | View on chart |
| STAA | ▲ Buy | Grant | 2,244 | $0 | 6/20/2024 | View on chart |
| STAA | ▲ Buy | Open Market | 850 | $26K | 12/6/2023 | View on chart |
| STAA | ▲ Buy | Grant | 1,477 | $0 | 12/4/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
STAAR Surgical Names New VP, Faces High Valuation Questions
STAAR Surgical appointed Andrew Pilon as Vice President of Business Development. Recent articles discuss whether the stock is undervalued or risky, noting its high trailing P/E of 283.5. The stock is currently trading near a key support level, with analyst targets ranging from $19.00 to $37.00.
STAAR Surgical Names New VP, Faces High Valuation Questions. STAAR Surgical appointed Andrew Pilon as Vice President of Business Development. Recent articles discuss whether the stock is undervalued or risky, noting its high trailing P/E of 283.5. The stock is currently trading near a key support level, with analyst targets ranging from $19.00 to $37.00.